Biotechnology and biomedical engineering are distinct yet impactful fields shaping healthcare's future. Biotechnology delves ...

The FDA issued a complete response letter to Genentech indicating it cannot approve the company’s biologic license ...

Genentech, part of the Roche Group ( OTCQX:RHHBY) ( OTCQX:RHHBF) ( OTCPK:RHHVF ), announced that the U.S. FDA has rejected ...

The FDA has declined to approve Columvi, in combination with the chemo regimen GemOx, for the treatment of second-line DLBCL ...

New data shows which companies are hiring the most UC alumni, and what kinds of jobs they are getting hired for. The UC ...

Seven biotech unicorns are advancing AI-powered drug discovery and development—but must contend with a difficult investing ...

Genentech is planning a massive overhaul of its 207-acre South San Francisco campus that could cost between $3B and $5B by the time the multiphase project is complete, according to the San Francisco ...

The survey shows the evolving landscape of nAMD and DME treatments, highlighting physician preferences, payer influences, and ...

News & Observer readers comments on NC's business ranking, speeding in a Raleigh area, a gun bill, flooding, Thom Tillis, plastic bags | Opinion ...

Here's what lies ahead Drug giant promises $50 billion U.S. investment Drug giant promises $50 billion U.S. investment Bay ...

Patients with neuro conditions are asked to consult with their neurologist, above all else, before seeking out therapeutic ...

Half of the year is over! So, which pharmaceutical giant outpaces the others? Sharp investors wonder whose market ...